Demand for semaglutide, sold under the brand names Ozempic, Rybelsus, and Wegovy, as well as another GLP-1 drug called tirzepatide (more commonly known as Mounjaro and Zepbound) soon soared, with one poll published in May finding that one American adult in eight had been prescribed a GLP-1 at some point
The Guideline 2024 multi-society guidance endorses continuing GLP-1 receptor agonists for most patients when teams evaluate and mitigate risk
More ways to help your patients with T2D Check your patients' coverage and view savings offer Resources are available to help patients start on Ozempic CDC=Centers for Disease Control
Find activities that you enjoy, such as walking, swimming, or dancing, to make exercise feel more like a pleasure than a chore
It's like only checking the engine after your car breaks downinstead of listening when the check engine light first comes on
Medical guidelines do not recommend combining multiple forms or brands of semaglutide